Celso Dias, MD
Vascular Surgery · Rochester, NYNPI 1396994109
Payments from drug & device makers
Across 219 payments — averaging $104.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$14K
- Medtronic$4K
- Cardiovascular Systems Inc.$1K
- W. L. Gore & Associates, Inc.$895
- Boston Scientific$793
- Terumo Medical Corporation$733
- plus $2K from 4 others
What the payments were for
- Consulting fees$4502%
- Food & beverage$8,50237%
- Other$13,89361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 6 | $14,254 |
| Medtronic(2 entities) | 84 | $3,574 |
| Cardiovascular Systems Inc. | 42 | $1,020 |
| W. L. Gore & Associates, Inc. | 13 | $895 |
| Boston Scientific | 31 | $793 |
| Terumo Medical Corporation | 11 | $733 |
| Abbott | 19 | $725 |
| Philips North America LLC | 9 | $460 |
| Cook Medical LLC | 3 | $323 |
| Solventum Corporation | 1 | $70 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$13,995
- Abre$1,248
- R2P MISAGO$450
- ENDURANT IIS$266
- Peripheral Orbital Atherectomy System$233
- Cook Medical AAA$226
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$224
- AngioVac$158
- JETi Peripheral Catheter$150
- Valiant Captivia$149
- VIABAHN VBX Balloon Expandable Endoprosthesis$145
- JETi All In One Non-Sterile Kit$145
- Diamondback Peripheral$141
- VIABAHN Endoprosthesis$138
- Endurant$136
- ELUVIA$120
- IN.PACT Admiral$120
- GENERAL VASCULAR INTERVENTION$113
- GENERAL METALLIC STENTS$112
- (4067) Tack Endo Sys BTK$111
How this compares
$22,845 in reported general payments places this provider in the 75th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 20 | $92 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Rochester
- Michael StonerRochester$328K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.7M
- John LantisNew York$1.4M
- Sonya NoorBuffalo$1.2M
- Brian DerubertisNew York$1M
- Thomas MaldonadoNew York$1M
- James McKinseyNew York$750K
- Peter FariesNew York$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.